6 Pages
English

Next Generation Sequencing Bioinformatics Heats up: Nearing $1000 Genome Sparks Soaring Data Output

Gain access to the library to view online
Learn more

Description

Next Generation SequencingNext Generation Sequencing Bioinformatics Heats up: Nearing $1000 Genome Sparks Soaring Data Output PR Newswire MOUNTAIN VIEW, California, Nov. 12, 2013 -- Frost & Sullivan: Healthcare innovation hinges on managing escalating amounts of data priming to more than triple the market The decreasing cost of genome sequencing lends momentum to the global next-generation sequencing (NGS) informatics market. As affordability drives adoption of genome sequencing in multiple end-user segments, an enormous output of NGS data to store and analyze is an overwhelming result. While primary and secondary data analysis tools are likely to become a commodity as pipelines standardize, the high-value tertiary data analysis segment used for biological interpretation and clinical reporting will drive revenue growth. New analysis from Frost & Sullivan's (http://www.lifesciences.frost.com) Global Next Generation Sequencing Informatics Market finds the market earned revenue of $170 million in 2012 and estimates this to reach $580 million in 2018 at an impressive compound annual growth rate (CAGR) of 22.7 percent. The research covers commercial primary and secondary data analysis tools, storage, computing, commercial biological interpretation and reporting tools, NGS informatics services, and laboratory information management systems across North America, Europe, Asia, and rest of world.

Subjects

Informations

Published by
Published 12 November 2013
Reads 6
Language English

Exrait

Next Generation Sequencing Bioinformatics Heats up: Nearing $1000 Genome Sparks Soaring Data Output

PR Newswire

-- Frost & Sullivan: Healthcare innovation hinges on managing escalating amounts of data priming to more than triple the market

The decreasing cost of genome sequencing lends momentum to the global next-generation sequencing (NGS) informatics market. As affordability drives adoption of genome sequencing in multiple end-user segments, an enormous output of NGS data to store and analyze is an overwhelming result. While primary and secondary data analysis tools are likely to become a commodity as pipelines standardize, the high-value tertiary data analysis segment used for biological interpretation and clinical reporting will drive revenue growth.